Xeris Biopharma Holdings (XERS) Exchange Rate Effect (2020 - 2022)

Xeris Biopharma Holdings (XERS) has reported Exchange Rate Effect for 3 consecutive years, with $1000.0 the latest figure, recorded in Q3 2022.

• For the quarter ending Q3 2022, Exchange Rate Effect rose 150.0% year-over-year to $1000.0; the trailing twelve-month figure through Jun 2023 stood at $1000.0 (up 120.0% YoY), and the FY2021 full-year result was -$3000.0, up 86.36% from the prior year.
• Exchange Rate Effect climbed to $1000.0 in Q3 2022 per XERS's latest filing, from -$1000.0 in the prior quarter.
• Across five years, Exchange Rate Effect topped out at $6000.0 in Q4 2020 and bottomed at -$2000.0 in Q3 2021.
• Historically, Exchange Rate Effect has averaged $500.0 across 3 years, with a median of $0.0 in 2021.
• The sharpest annual moves came in 2021 and 2022: Exchange Rate Effect plunged 133.33% in 2021, then jumped 150.0% in 2022.
• Over 3 years, Exchange Rate Effect stood at $6000.0 in 2020, then tumbled by 133.33% to -$2000.0 in 2021, then surged by 150.0% to $1000.0 in 2022.
• According to Business Quant data, Exchange Rate Effect over the past three periods registered $1000.0, -$1000.0, and -$2000.0 for Q3 2022, Q1 2022, and Q4 2021 respectively.